Liothyronine Sodium (Carilion Materials Management)
Welcome to the PulseAid listing for the Liothyronine Sodium drug offered from Carilion Materials Management. This l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Carilion Materials Management |
NON-PROPRIETARY NAME: | Liothyronine Sodium |
SUBSTANCE NAME: | LIOTHYRONINE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2009-03-23 |
END MARKETING DATE: | 0000-00-00 |
Liothyronine Sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Liothyronine Sodium from Carilion Materials Management |
LABELER NAME: | Carilion Materials Management |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(ug/1) |
START MARKETING DATE: | 2009-03-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68151-0237_efcddc0e-454b-45e3-b78c-1e9f5a2cdb8a |
PRODUCT NDC: | 68151-0237 |
APPLICATION NUMBER: | ANDA090097 |
Other LIOTHYRONINE SODIUM Pharmaceutical Manufacturers / Labelers: